BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27277835)

  • 1. Regulation of the RhoA/ROCK/AKT/β-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Song GL; Jin CC; Zhao W; Tang Y; Wang YL; Li M; Xiao M; Li X; Li QS; Lin X; Chen WW; Kuang J
    Int J Oncol; 2016 Aug; 49(2):646-56. PubMed ID: 27277835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
    Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M
    Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
    Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
    Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.
    Xiao M; Tang Y; Chen WW; Wang YL; Yang L; Li X; Song GL; Kuang J
    Tumour Biol; 2016 Feb; 37(2):2353-63. PubMed ID: 26373733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
    Yang L; Xiao M; Li X; Tang Y; Wang YL
    Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells in vivo.
    Xu JX; Xiong W; Zeng Z; Tang Y; Wang YL; Xiao M; Li M; Li QS; Song GL; Kuang J
    Mol Med Rep; 2017 Mar; 15(3):1222-1228. PubMed ID: 28138708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
    Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
    Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway.
    Long WB; Pu X; Tang Y; Li M; Liu Y; She Q; Wang YL; Guo QX
    Curr Med Sci; 2022 Aug; 42(4):733-741. PubMed ID: 35798928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ART1 silencing enhances apoptosis of mouse CT26 cells via the PI3K/Akt/NF-κB pathway.
    Xiao M; Tang Y; Wang YL; Yang L; Li X; Kuang J; Song GL
    Cell Physiol Biochem; 2013; 32(6):1587-99. PubMed ID: 24335275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
    Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
    Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
    Zhou L; Zhan ML; Tang Y; Xiao M; Li M; Li QS; Yang L; Li X; Chen WW; Wang YL
    Int J Oncol; 2018 Oct; 53(4):1613-1624. PubMed ID: 30066849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.
    Park SY; Lee SJ; Cho HJ; Kim TW; Kim JT; Kim JW; Lee CH; Kim BY; Yeom YI; Lim JS; Lee Y; Lee HG
    Oncotarget; 2016 Feb; 7(8):9501-12. PubMed ID: 26824987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.